港股異動丨通達集團飆升16.67% 攜手基石科技推進電動車充電站業務
格隆匯11月25日丨通達集團飆升16.67%,報0.133港元創逾三個月新高,總市值13億港元。通達集團宣佈,於2022年11月25日,公司與基石科技控股有限公司訂立有關戰略合作的諒解備忘錄,雙方將推進電動車充電站的研發、推廣其於香港及內地的使用。董事會認為,諒解備忘錄貫徹集團開拓"智能城市"新商機的策略。倘諒解備忘錄項下擬進行交易得以實現,預期集團的投資組合及業務變得多元化將為公司股東帶來更佳回報。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.